Literature DB >> 3330403

[Pharmacokinetics of pyronaridine in malaria patients].

Z Feng, Z F Wu, C Y Wang, N X Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3330403

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN： 0253-9756


× No keyword cloud information.
  3 in total

1.  Review of pyronaridine anti-malarial properties and product characteristics.

Authors:  Simon L Croft; Stephan Duparc; Sarah J Arbe-Barnes; J Carl Craft; Chang-Sik Shin; Lawrence Fleckenstein; Isabelle Borghini-Fuhrer; Han-Jong Rim
Journal:  Malar J       Date:  2012-08-09       Impact factor: 2.979

2.  Development of antimalarial drugs and their application in China: a historical review.

Authors:  Chang Chen
Journal:  Infect Dis Poverty       Date:  2014-03-20       Impact factor: 4.520

3.  Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.

Authors:  Matthias Rottmann; Brian Jonat; Christin Gumpp; Satish K Dhingra; Marla J Giddins; Xiaoyan Yin; Lassina Badolo; Beatrice Greco; David A Fidock; Claude Oeuvray; Thomas Spangenberg
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.